Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Jubilant Cadista Pharmaceuticals Inc.

NDC labeler code: 59746

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

51Products (NDC)

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
August 4, 2025ANDA211219 Eslicarbazepine acetate
ESLICARBAZEPINE ACETATE
Jubilant Generics
March 6, 2025ANDA202954 Sildenafil
SILDENAFIL CITRATE
Jubilant Generics
December 20, 2024ANDA201156 Sildenafil
SILDENAFIL CITRATE
Jubilant Generics
December 1, 2023ANDA217675 Methenamine hippurate
METHENAMINE HIPPURATE
Jubilant Cadista
August 18, 2022ANDA216594 Carbamazepine
CARBAMAZEPINE
Umedica
February 18, 2022ANDA211013 Nitrofurantoin (monohydrate/macrocrystals)
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Inventia
February 9, 2022ANDA211320 Chlorthalidone
CHLORTHALIDONE
Adaptis
October 3, 2018ANDA208236 Roflumilast
ROFLUMILAST
Pharmazone
February 23, 2015ANDA203534 Irbesartan
IRBESARTAN
Jubilant Generics
January 5, 2015ANDA203536 Valsartan
VALSARTAN
Jubilant Generics
September 28, 2012ANDA090802 Tacrolimus
TACROLIMUS
Panacea
September 18, 2012ANDA201170 Losartan potassium
LOSARTAN POTASSIUM
Jubilant Cadista
September 18, 2012ANDA201845 Losartan potassium and hydrochlorothiazide
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Jubilant Cadista
September 12, 2012ANDA202280 Escitalopram
ESCITALOPRAM OXALATE
Jubilant Cadista
April 3, 2012ANDA201506 Valacyclovir
VALACYCLOVIR HYDROCHLORIDE
Jubilant Generics
January 27, 2009ANDA079132 Lamotrigine
LAMOTRIGINE
Jubilant Cadista
April 19, 2006ANDA077563 Cyclobenzaprine hydrochloride
CYCLOBENZAPRINE HYDROCHLORIDE
Jubilant Cadista
December 20, 2004ANDA075317 Terazosin hydrochloride
TERAZOSIN HYDROCHLORIDE
Jubilant Cadista
February 27, 1998ANDA040268 Prochlorperazine
PROCOMP
Jubilant Cadista

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2022

  1. December 27, 2022 · Class III · Terminated · D-0096-2023 · Prochlorperazine

    Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

    Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Maryland 21801, NDC 59746-113-06

  2. July 18, 2022 · Class II · Terminated · D-1293-2022 · Irbesartan

    Failed dissolution specifications.

    Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90

  3. July 18, 2022 · Class II · Terminated · D-1294-2022 · Irbesartan

    Failed Dissolution Specifications

    Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90

2021

  1. March 15, 2021 · Class II · Terminated · D-0461-2021 · Valsartan

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Valsartan Tablets USP 40 mg 30 Scored Tablets Rx Only NDC 59746-360-30 Manufactured by: Jubilant Generics Ltd. Roorkee-247661, India

2020

  1. May 26, 2020 · Class III · Terminated · D-1281-2020 · Lamotrigine

    Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

    Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 5974

2018

  1. August 14, 2018 · Class III · Terminated · D-1104-2018 · Valsartan

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

    Valsartan Tablets USP, 80 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-361-90

  2. August 14, 2018 · Class III · Terminated · D-1103-2018 · Valsartan

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

    Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30

  3. August 14, 2018 · Class III · Terminated · D-1105-2018 · Valsartan

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

    Valsartan Tablets USP, 160 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-362-90

2014

  1. July 11, 2014 · Class II · Terminated · D-1500-2014 · Losartan potassium and hydrochlorothiazide

    Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.

    Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →